Therapeutic trials in congestive heart failure
Related pages
- ACE inhibitors in heart failure
- Angiotensin II receptor inhibitors in heart failure
- Cardiac Insufficiency Bisoprolol Study II
- RALES study
- Digoxin in heart failure - trial evidence
- IMPRESS trial
- Carvedilol or Metoprolol European Trial (COMET)
- CHARM trial programme
- EPHESUS trial (treatment of heart failure)
- African-American Heart Failure Trial (A-HeFT), treatment with fixed-dose combined isosorbide dinitrate / hydralazine
- PARADIGM-HF - angiotensin receptor neprilysin inhibition (ARNI) versus enalapril in reduced ejection fraction heart failure (HFrEF)
- PARAGON - HF sacubutril versus valsartan in HFpEF heart failure
- EMPEROR - Reduced (empagliflozin in reduced ejection fraction heart failure)
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction (DAPA-HF)
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.